{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T18:14:09Z","timestamp":1785262449604,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejca.2025.115229","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T11:54:38Z","timestamp":1736423678000},"page":"115229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Ossifying fibromyxoid tumours: A case series"],"prefix":"10.1016","volume":"217","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9776-9021","authenticated-orcid":false,"given":"Javier","family":"Pozas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khin","family":"Thway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myles","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6946-0820","authenticated-orcid":false,"given":"Aisha","family":"Miah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7509-1555","authenticated-orcid":false,"given":"Andrea","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3972-5087","authenticated-orcid":false,"given":"Paul","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4173-3844","authenticated-orcid":false,"given":"Robin L.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejca.2025.115229_bib1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.32074\/1591-951X-213","article-title":"The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives","volume":"113","author":"Sbaraglia","year":"2021","journal-title":"Pathologica"},{"issue":"7","key":"10.1016\/j.ejca.2025.115229_bib2","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1097\/PAS.0b013e318160736a","article-title":"Ossifying fibromyxoid tumor of soft parts--a clinicopathologic and immunohistochemical study of 104 cases with long-term follow-up and a critical review of the literature","volume":"32","author":"Miettinen","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.ejca.2025.115229_bib3","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.5858\/arpa.2019-0371-RA","article-title":"Ossifying Fibromyxoid Tumor: A Review With Emphasis on Recent Molecular Advances and Differential Diagnosis","volume":"143","author":"Carter","year":"2019","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"10.1016\/j.ejca.2025.115229_bib4","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/cup.12514","article-title":"Ossifying fibromyxoid tumor: a clinicopathologic analysis of 26 subcutaneous tumors with emphasis on differential diagnosis and prognostic factors","volume":"42","author":"Atanaskova Mesinkovska","year":"2015","journal-title":"J Cutan Pathol"},{"issue":"4","key":"10.1016\/j.ejca.2025.115229_bib5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00000478-200304000-00001","article-title":"Ossifying fibromyxoid tumor of soft parts: a clinicopathologic study of 70 cases with emphasis on atypical and malignant variants","volume":"27","author":"Folpe","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.ejca.2025.115229_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/gcc.22132","article-title":"Novel ZC3H7B-BCOR, MEAF6-PHF1, and EPC1-PHF1 fusions in ossifying fibromyxoid tumors\u2014molecular characterization shows genetic overlap with endometrial stromal sarcoma","volume":"53","author":"Antonescu","year":"2014","journal-title":"Genes, Chromosomes Cancer"},{"issue":"8","key":"10.1016\/j.ejca.2025.115229_bib7","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1128\/MCB.02017-07","article-title":"Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27 trimethylation in vivo","volume":"28","author":"Sarma","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"9","key":"10.1016\/j.ejca.2025.115229_bib8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/gcc.22755","article-title":"Novel recurrent PHF1-TFE3 fusions in ossifying fibromyxoid tumors","volume":"58","author":"Suurmeijer","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"10.1016\/j.ejca.2025.115229_bib9","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/00000478-198910000-00001","article-title":"Ossifying fibromyxoid tumor of soft parts. A clinicopathological analysis of 59 cases","volume":"13","author":"Enzinger","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2025.115229_bib10","doi-asserted-by":"crossref","DOI":"10.25259\/SNI_827_2021","article-title":"Malignant ossifying fibromyxoid tumor of the brain treated with post-operative fractionated stereotactic radiation therapy: A case report and literature review","volume":"12","author":"Beyer","year":"2021","journal-title":"Surg Neurol Int"},{"issue":"6","key":"10.1016\/j.ejca.2025.115229_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/014556131409300608","article-title":"Ossifying fibromyxoid tumor metastatic to the thyroid: a case report and review of the literature","volume":"93","author":"Lastra","year":"2014","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.ejca.2025.115229_bib12","doi-asserted-by":"crossref","unstructured":"Patel H., Shah V., Patel N., Tatsas A., Palasamudram Shekar S. Malignant Ossifying Fibromyxoid Tumor of the Chest Wall Metastasized to the Lung Even After Complete Resectioning of the Primary Tumor - A Case Report and a Comprehensive Review. Cureus. 15(9):e44793. doi:10.7759\/cureus.44793.","DOI":"10.7759\/cureus.44793"},{"key":"10.1016\/j.ejca.2025.115229_bib13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13569-017-0086-2","article-title":"Response to isolated limb perfusion and chemotherapy with epirubicin plus ifosfamide in a metastatic malignant ossifying fibromyxoid tumor","volume":"7","author":"Provenzano","year":"2017","journal-title":"Clin Sarcoma Res"},{"issue":"2","key":"10.1016\/j.ejca.2025.115229_bib14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0165-4608(01)00581-7","article-title":"Ossifying fibromyxoid tumor of soft parts.: Cytogenetic findings","volume":"133","author":"Nishio","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"issue":"11","key":"10.1016\/j.ejca.2025.115229_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014060","article-title":"Gemcitabine functions epigenetically by inhibiting repair mediated DNA demethylation","volume":"5","author":"Sch\u00e4fer","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ejca.2025.115229_bib16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/j.seminhematol.2013.01.005","article-title":"DNA Methyltransferases in Hematologic Malignancies","volume":"50","author":"Li","year":"2013","journal-title":"Semin Hematol"},{"issue":"11","key":"10.1016\/j.ejca.2025.115229_bib17","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S1470-2045(20)30451-4","article-title":"Tazemetostat in advanced epithelioid sarcoma with loss of INI1\/SMARCB1: an international, open-label, phase 2 basket study","volume":"21","author":"Gounder","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2025.115229_bib18","series-title":"In: Rose NR, Mackay IR, eds. The Autoimmune Diseases","first-page":"381","article-title":"Chapter 28 - Epigenetics and Autoimmune Diseases","author":"Zouali","year":"2014"},{"issue":"8","key":"10.1016\/j.ejca.2025.115229_bib19","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1158\/0008-5472.CAN-23-1789","article-title":"TFE3-Splicing Factor Fusions Represent Functional Drivers and Druggable Targets in Translocation Renal Cell Carcinoma","volume":"84","author":"Damayanti","year":"2024","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ejca.2025.115229_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13046-023-02667-4","article-title":"High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma","volume":"42","author":"Lang","year":"2023","journal-title":"J Exp Clin Cancer Res"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925000103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925000103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:44:57Z","timestamp":1777265097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804925000103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":20,"alternative-id":["S0959804925000103"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2025.115229","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ossifying fibromyxoid tumours: A case series","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2025.115229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"115229"}}